VSG also leads to decreased accessibility in genes related to insulin resistance and type 2 diabetes, such as Scd1, Serpine1, and Fkbp5, and these changes are found in specific adipocyte subtypes. The gene discussed is SCD; the disease is type 2 diabetes mellitus.